Mochida Pharmaceutical Overview
- Founded
-
1913
- Status
-
Public
- Employees
-
2,047
- Stock Symbol
-
4534
- Investments
-
2
- Share Price
-
$23.36
- (As of Friday Closing)
Mochida Pharmaceutical General Information
Description
Mochida Pharmaceutical Co Ltd is a major drug manufacturing company that operates in the field of medical care through its pharmaceuticals, healthcare products, and medical equipment businesses. The company's pharmaceuticals business aims to develop and market a broad spectrum of innovative new drugs. One of Mochida's main objectives is to maximize the business performance of its drugs after they are developed and released. The company also creates skin care products for the general public, and these are supplied through pharmacies, drugstores, and mail-order sales.
Contact Information
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Stock Exchange
TKS
Primary Office
- 1-7, Yotsuya
- Tokyo, Shinjuku-Ku 160-8515
- Japan
+81 00-0000-0000
Mochida Pharmaceutical Stock Performance
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $23.36 | $23.41 | $22.22 - $33.84 | $874M | 37.4M | 39.8K | $2.49 |
Mochida Pharmaceutical Financials Summary
|
In Thousands, USD |
TTM 30-Jun-2022 | FY 2022 31-Mar-2022 | FY 2021 31-Mar-2021 | FY 2020 31-Mar-2020 |
|---|---|---|---|---|
| EV | 390,761 | 621,983 | 905,933 | 980,524 |
| Revenue | 941,637 | 980,735 | 971,289 | 936,252 |
| EBITDA | 153,797 | 138,052 | 82,781 | |
| Net Income | 94,335 | 94,078 | 80,979 | 42,287 |
| Total Assets | 1,188,607 | 1,336,679 | 1,466,619 | 1,457,236 |
| Total Debt | 0 | 0 | 0 | 0 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Mochida Pharmaceutical Patents
Mochida Pharmaceutical Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| JP-2022097087-A | Composition for external use containing tranexamic acid | Pending | 18-Dec-2020 | ||
| US-20220193118-A1 | Method for suppressing intervertebral disc pain | Pending | 13-Nov-2020 | 000000000 | |
| JP-2021008518-A | Self-emulsifying composition of ω-3 fatty acid | Pending | 21-Oct-2020 | 0 | |
| US-20210379004-A1 | Method for preventing occurrence of cardiovascular event in multiple risk patient | Inactive | 03-Jun-2020 | 00000000 | |
| JP-2021109006-A | Injection device | Active | 14-Jan-2020 |
Mochida Pharmaceutical Executive Team (3)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Keiichi Sagisaka | Board Member & Executive | ||
| Kiyoshi Mizuguchi | Board Member & Executive | ||
| Chu Sakata | Board Member & Senior Executive Vice President |
Mochida Pharmaceutical Board Members (4)
| Name | Representing | Role | Since |
|---|---|---|---|
| 000 000000 | Mochida Pharmaceutical | Board Member & Senior Executive Vice President | 000 0000 |
| 0000000 00000000 | Mochida Pharmaceutical | Board Member & Executive | 000 0000 |
| 0000000 000000000 | Mochida Pharmaceutical | Board Member & Executive | 000 0000 |
| 00000 00000000 | Mochida Pharmaceutical | Board Member | 000 0000 |
Mochida Pharmaceutical Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Mochida Pharmaceutical Investments (2)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 00000 | 29-Mar-2022 | 00000 0000 | 00.000 | Discovery Tools (Healthcare) | |
| Mochida Siemens Medical Systems | 01-Jan-2004 | Joint Venture | Diagnostic Equipment |